Key insights
- Cathie Wood's ARK ETF sold shares of Meta, Nvidia, AMD, Deere, Archer Aviation, Block, Roku and Recursion Pharmaceuticals while increasing its position in Tempus AI. These moves suggest a shift away from established tech and industrial companies towards emerging opportunities. The impact on US equities is slightly negative, reflecting potential profit-taking in large-cap tech.
Cathie Wood’s ARK ETF published their daily trades for Thursday, March 26th, 2026, revealing significant activity in the tech sector. The largest transaction of the day was the sale of 76,622 shares of Meta Platforms Inc (NASDAQ:META), amounting to $45,581,661. This marks a continued divestment from Meta, following smaller sales earlier in the week.
Another notable transaction was the sale of 155,441 shares of Nvidia Corp (NASDAQ:NVDA) for $27,774,197. This sale follows a trend of reducing exposure to Nvidia, as seen in previous trading days.
ARK also sold 38,245 shares of Advanced Micro Devices Inc (NASDAQ:AMD), totaling $8,424,226, and 94,440 shares of Deere & Co (NYSE:DE) for $5,458,537. These moves indicate a shift away from some of the larger tech and industrial players.
In addition, ARK reduced its holdings in Archer Aviation Inc (NYSE:ACHR) by 436,322 shares, valued at $2,425,950, and in Block Inc (NYSE:XYZ) by 86,372 shares, totaling $5,183,183.
On the buying side, ARK made a significant purchase of 60,973 shares of Tempus AI Inc (TEM), investing $2,851,097. This acquisition continues ARK’s recent pattern of increasing its stake in Tempus AI.
Other sales included 75,721 shares of Roku Inc (NASDAQ:ROKU) for $7,198,038, 86,372 shares of Block Inc (NYSE:XYZ) for $5,183,183, and 19,132 shares of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) for $606,490.
Each of these trades reflects ARK’s ongoing strategy to recalibrate its portfolio, focusing on emerging opportunities while trimming positions in more established tech giants.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.